Meyka Pro banner
Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. (TMO) Stock Overview

Explore Thermo Fisher Scientific Inc.’s financial performance, market position, analyst ratings, and future outlook.

TMONYSE
HealthcareMedical - Diagnostics & Research
$628.15
$0.59(0.09%)
U.S. Market opens in 10h 15m

Thermo Fisher Scientific Inc. (TMO)

Meyka AI Score

Z

Key Financials

Market Cap233.4B
P/E Ratio33.67
EPS (TTM)$23.16
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$581.69
3 Months$610.87
1 Year Target$534.81

TMO Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Thermo Fisher Scientific Inc. (NYSE: TMO) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Thermo Fisher Scientific Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TMO on the NYSE shows an RSI of 73.39, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $534.81 for the NYSE listing.

Key metrics behind Thermo Fisher Scientific Inc.'s NYSE-traded stock include a P/E ratio of 33.67 and a market capitalization of 233.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TMO on the NYSE.

Price Performance (NYSE: TMO)

1-Day Change
-0.09%
5-Day Change
3.002%
1-Month Change
10.54%
3-Month Change
40.16%
6-Month Change
22.29%
Year-to-Date (YTD) Change
8.41%
1-Year Change
28.00%
3-Year Change
15.98%
5-Year Change
14.61%
All-Time (Max) Change
49753.97%

Contact Information

781 622 1000
168 Third Avenue, Waltham, MA, 02451

Company Facts

1,250,000 Employees
IPO DateMar 17, 1980
CountryUS
Actively Trading

Frequently Asked Questions